Business Of Biotech
door Ben Comer
Preparing For Commercial Launch In Oncology With Candel…
Over deze podcast
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.
Afleveringen
De nieuwste 50 van 333 afleveringen
- Preparing For Commercial Launch In Oncology With Candel Therapeutics' Paul Peter Tak, M.D., Ph.D. · 56 min · Aflevering 332We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Paul Peter Tak, M.D., Ph.D., CEO at Candel Therapeutics, talks about the…
- Managing Risk And Development In A Growing Neuroscience Portfolio With AbbVie's Sean Kelley · 50 min · Aflevering 331We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Sean Kelley, Vice President for neuroscience and toxins, Portfolio…
- Translating A New Discovery Into A Novel Cancer Therapy With Grid Therapeutics' Ned Patz, M.D. · 54 min · Aflevering 330We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Edward (Ned) Patz, M.D., Cofounder and CEO at Grid Therapeutics…
- Bioprinting 3D Human Tissue To Discover And Test New Treatments With Viscient Bio's Keith Murphy · 57 min · Aflevering 329We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Keith Murphy, CEO at Viscient Biosciences, unpacks how 3D human tissue…
- Investing In Tomorrow's CNS Breakthroughs With Breyer Capital's Bret Bostwick, M.D. · 47 min · Aflevering 328We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Bret Bostwick, M.D., Venture Partner at Breyer Capital, a family office…
- AI, China, And Biotech Investing With SR One's Simeon George, M.D. · 49 min · Aflevering 327We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Simeon George, M.D., Cofounder and CEO at SR One Capital Management…
- Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding · 60 min · Aflevering 326We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Cyriac Roeding talks about cofounding and leading Earli, a "bioAI"…
- Growing And Scaling A Radiopharmaceuticals Company With AdvanCell's Philina Lee, Ph.D. · 55 min · Aflevering 325We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Philina Lee, Ph.D., CEO at AdvanCell, explains how lead-based targeted…
- Finding New Opportunities In Obesity With Moonwalk Bioscience's Alex Aravanis, M.D., Ph.D. · 47 min · Aflevering 324We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Alex Aravanis, M.D., Ph.D., CEO of Moonwalk Biosciences, talks about the…
- Biotech Finance And Investor Update With Independent Board Director Allan Shaw · 55 min · Aflevering 323We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Independent Board Director and five-time public company CFO Alan Shaw…
- Funding A Virtual Biotech Without Institutional Capital With Sarcomatrix's David Craig · 56 min · Aflevering 322We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, David Craig, Cofounder, President, and CEO at Sarcomatrix, explains why…
- Picking Biotech Winners Beyond The Hype Cycle With Andera Partners' Olivier Litzka · 58 min · Aflevering 321We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Olivier Litzka, Partner at Andera Partners, talks about what it really…
- Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil · 56 min · Aflevering 320We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Omar Khalil, Managing Director at Santé Ventures, describes forming and…
- Getting To A First Product Approval With Celcuity's Brian Sullivan · 50 min · Aflevering 319We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Sullivan, CEO at Celcuity, talks about winning the company's first…
- Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings · 50 min · Aflevering 318We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Paul Hastings, Founding CEO and Board Member at Nkarta, an allogeneic…
- A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D. · 56 min · Aflevering 317We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Annette Bakker, Ph.D., CEO at the Children's Tumor Foundation, and…
- Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D. · 55 min · Aflevering 316We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Aris Baras, M.D., SVP, Head of Regeneron Genetics Center (RGC) and…
- Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D. · 56 min · Aflevering 315We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Matt Winton, Ph.D., Chief Commercial and Business Officer at CervoMed…
- BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin · 49 min · Aflevering 314We love to hear from our listeners. Send us a message. On the Business of Biotech this week, industry veteran Dr. Jeremy Levin, Founder, Chairman, and former CEO at Ovid…
- BoB@BIO: Biotech Investing And Deals With Sofinnova's Maha Radhakrishnan, M.D. · 39 min · Aflevering 313We love to hear from our listeners. Send us a message. This week's episode of the Business of Biotech was recorded at the BIO Convention in San Diego, where guest Maha…
- Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D. · 49 min · Aflevering 312We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Al Sandrock, M.D., Ph.D., President and CEO at Voyager Therapeutics…
- Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho · 55 min · Aflevering 311We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, William Ho, CEO of IN8bio, explains why gamma delta T cells may have an…
- Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D. · 55 min · Aflevering 310We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, William Soliman, Founder and CEO of the Accreditation Council for…
- The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry · 1 u 24 min · Aflevering 309We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Tyler Menichiello, chief editor at Bioprocess Online, host of the Better…
- Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D. · 50 min · Aflevering 308We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Jeff Jonas, M.D., CEO of Tortugas Neuroscience, talks about the…
- Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane · 55 min · Aflevering 307We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Neil McFarlane, CEO at Zevra Therapeutics, talks about transitioning to…
- Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D. · 51 min · Aflevering 306We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Marinna Madrid, Ph.D., Cofounder, Board Member, Chief Product and…
- Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D. · 54 min · Aflevering 305We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Wyatt McDonnell, Ph.D., cofounder and CEO at Infinimmune, talks about…
- From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D. · 56 min · Aflevering 304We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brett Monia, Ph.D., CEO at Ionis Pharmaceuticals, talks about how…
- Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary · 48 min · Aflevering 303We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we talk with NervGen leaders Adam Rogers, M.D., and Rich Macary about…
- The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw · 47 min · Aflevering 302We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, five-time public company CFO and seven-time public company board member…
- Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D. · 59 min · Aflevering 301We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we speak with Dr. Sarfaraz Niazi, Ph.D., about how biosimilar…
- Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor · 40 min · Aflevering 300We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Thijs Spoor, CEO at Perspective Therapeutics, a company developing Pb…
- Investing In Early-Stage Oncology With Yosemite's Dan McHugh · 56 min · Aflevering 299We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Dan McHugh, head of the investment team at Yosemite, explains the San…
- Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash · 51 min · Aflevering 298We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech we're speaking with Alan Bash, President, Carvykti, at Legend Biotech…
- Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D. · 54 min · Aflevering 297We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech we speak with Dr. Marc Hedrick, M.D., President and CEO at Plus…
- Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D. · 49 min · Aflevering 296We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech we speak with Rahul Aras, Ph.D., President and CEO at Iterion…
- Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D. · 54 min · Aflevering 295We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Thomas von Erlach, Ph.D., Cofounder and CEO at…
- An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D. · 58 min · Aflevering 294We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech we speak with Monika Sumra, Ph.D., about how leadership, culture, and…
- Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer · 57 min · Aflevering 293We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Jared Bauer, Cofounder and CEO at Seek Labs, talks about his adventures…
- Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie · 43 min · Aflevering 292We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Cindy Perettie, Executive Vice President and Global…
- BoB@JPM: Brian Hilberdink, Boehringer Ingelheim · 45 min · Aflevering 291We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Hilberdink, President of U.S. Human Pharma at Boehringer…
- BoB@JPM: Ron Cooper, enGene · 56 min · Aflevering 290We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech -- on location at the J.P. Morgan Healthcare Conference -- we're speaking…
- BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics · 36 min · Aflevering 289We love to hear from our listeners. Send us a message. The Business of Biotech was back in San Francisco for the J.P. Morgan Healthcare Conference (January 12 - 15) and this week…
- A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith · 59 min · Aflevering 288We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Kenneth Galbraith, CEO and Board Chair at Zymeworks…
- Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead · 1 u 21 min · Aflevering 287We love to hear from our listeners. Send us a message. This week's special holiday episode of the Business of Biotech brings seven chief editors from the Life Science Connect…
- Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos · 47 min · Aflevering 286We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks about his experiences…
- Modernizing Clinical Trial Operations With Merck's Jennifer Sheller · 56 min · Aflevering 285We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Jennifer Sheller, SVP and Head of Global Clinical Trial Operations at…
- Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D. · 56 min · Aflevering 284We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Bruce Culleton, M.D., CEO at ProKidney, talks about moving from academic…
- Engineering B Cells With Immusoft's Sean Ainsworth · 54 min · Aflevering 283We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Sean Ainsworth, CEO and Chairman at Immusoft, talks about transitioning…








